Table 4.
Baseline vs. Post-Decision Aid (DA) Comparison of Participants’ Scores on Psychosocial Measures by Gender, N=57
| Measure, Range | Males (N=21) | Females (N= 36) | ||
|---|---|---|---|---|
| Baseline | Post-DA | Baseline | Post-DA | |
|
|
||||
| Intention to test, % committed/probably | 62% | 67% | 83% | 83% |
|
|
||||
| M( SD) | M(SD) | M(SD) | M(SD) | |
|
|
||||
| State Anxiety, 20–80 | 26.9 (8.3) | 25.5 (5.7) | 26.2 (6.0) | 28.0 (8.0) |
| Depression (CES-D), 0–60a | 7.4 (8.1) | 3.2 (4.1) | 7.9 (7.3) | 8.6 (9.1) |
| Cancer-specific distress (IES), 0–75 | 8.9 (12.8) | 6.2 (9.6) | 10.0 (12.1) | 10.6 (13.8) |
| Cancer worries, 1–4 b | 1.3 (0.5) | 1.0 (0.4) | 1.4 (0.5) | 1.0 (0.5) |
| Perceived risk | ||||
| Developing cancer, 1–5 b | 3.3 (1.2) | 2.4 (1.2) | 3.7 (1.1) | 2.5 (1.0) |
| Carrying a p53 mutation, 0–100% | 41.0 (28.2) | 39.9 (24.6) | 48.5 (24.1) | 55.4 (30.0) |
| Self-efficacy, 0–100% | ||||
| Have genetic counseling | 83.3 (18.5) | 81.0 (30.8) | 88.8 (17.3) | 91.1 (18.0) |
| Have genetic testing | 82.1 (27.4) | 92.8 (21.9) | 88.7 (19.8) | 90.6 (21.7) |
| Cope with positive test result | 85.2 (23.5) | 81.9 (34.8) | 85.3 (18.3) | 85.3 (21.7) |
| Decisional conflict, 1–5 b | 2.3 (0.5) | 1.8 (0.6) | 2.1 (0.7) | 1.8 (0.6) |
| Knowledge, 0–100% correct b | 67% | 77% | 66% | 75% |
a
p <0.05 (baseline to post DA), males only
b
p <0.01 (baseline to post DA), males and females